[HTML][HTML] Stromal and immune cells in gut fibrosis: the myofibroblast and the scarface

V Valatas, E Filidou, I Drygiannakis… - Annals of …, 2017 - ncbi.nlm.nih.gov
Post-inflammatory scarring is the end-result of excessive extracellular matrix (ECM)
accumulation and tissue architectural destruction. It represents a failure to effectively …

Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs-a systematic review

D Bettenworth, F Rieder - Fibrogenesis & tissue repair, 2014 - Springer
Crohn's disease (CD) is a chronic remitting and relapsing disease. Fibrostenosing
complications such as intestinal strictures, stenosis and ultimately obstruction are some of its …

Transforming growth factor-β promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1/2 mitogen activated protein kinase cell signaling

JJW Mulsow, RWG Watson, JM Fitzpatrick… - Annals of …, 2005 - journals.lww.com
Objective: To assess the role of fibroblasts, transforming growth factor (TGF)-β, and cell
signal pathways in promoting fibrosis in Crohn's disease (CD). Summary Background Data …

Inhibition of fibroblast activation protein restores a balanced extracellular matrix and reduces fibrosis in Crohn's disease strictures ex vivo

M Truffi, L Sorrentino, M Monieri… - Inflammatory Bowel …, 2018 - academic.oup.com
Background Crohn's disease (CD) is a chronic bowel inflammation that ultimately leads to
fibrosis, for which medical therapy is currently unavailable. Fibrotic strictures in CD are …

[HTML][HTML] Interleukin 1 is a key driver of inflammatory bowel disease-demonstration in a murine IL-1Ra knockout model

RH Dosh, N Jordan-Mahy, C Sammon, C Le Maitre - Oncotarget, 2019 - ncbi.nlm.nih.gov
Abstract Interleukin 1 (IL-1) is an important mediator of inflammation and tissue damage in
inflammatory bowel disease (IBD). The balance between IL-1 and IL-1Ra as a natural …

Infiltrating CCR2+ monocytes and their progenies, fibrocytes, contribute to colon fibrosis by inhibiting collagen degradation through the production of TIMP-1

N Kuroda, M Masuya, I Tawara, J Tsuboi, M Yoneda… - Scientific reports, 2019 - nature.com
Intestinal fibrosis is a serious complication in inflammatory bowel disease (IBD). Despite the
remarkable success of recent anti-inflammatory therapies for IBD, incidence of intestinal …

Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis

P Garg, M Rojas, A Ravi, K Bockbrader… - The Journal of …, 2006 - journals.aai.org
The matrix metalloproteinases (MMPs), MMP-2 and MMP-9, share structural and substrate
similarities and are up-regulated during human as well as animal models of inflammatory …

Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis

I Drygiannakis, V Valatas, O Sfakianaki… - Journal of Crohn's …, 2013 - academic.oup.com
Background and aims: Colonic epithelial cells and adjacent subepithelial myofibroblasts are
important counterparts in the pathogenesis of intestinal inflammation and fibrosis. We …

Transforming growth factor‐beta type 1 receptor (ALK5) and Smad proteins mediate TIMP‐1 and collagen synthesis in experimental intestinal fibrosis

C Medina, MJ Santos‐Martinez… - The Journal of …, 2011 - Wiley Online Library
Transforming growth factor β (TGF‐β) is known to play a key role in intestinal fibrosis;
however, the underlying mechanisms are not well understood. TGF‐β signal transduction is …

Alternative drug delivery approaches for the therapy of inflammatory bowel disease

Y Meissner, A Lamprecht - Journal of pharmaceutical sciences, 2008 - Elsevier
This article shall give an overview on drug delivery systems for new therapeutic strategies in
the treatment of inflammatory bowel disease. The various features of the different …